faculty photo

Angela M DeMichele, MD MSCE

Alan and Jill Miller Professor in Breast Cancer Excellence
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-104
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-349-5730
Fax: 215-615-3349
Education:
B.A. (Biochemistry)
Brown University, 1988.
M.D. (Medicine)
Washington University School of Medicine, 1991.
M.S.C.E. (Clinical Epidemiology)
University of Pennsylvania, School of Medicine, 2001.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

O'Shaughnessy Joyce, DeMichele Angela, Ma Cynthia X, Richards Paul, Yardley Denise A, Wright Gail Shaw, Kalinsky Kevin, Steis Ronald, Diab Sami, Kennealey Gerard, Geschwindt Ryan, Jiang Wei, Rugo Hope S: A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation. Breast cancer research and treatment 170(3): 547-557, Aug 2018.

Banerjee Sagarika, Tian Tian, Wei Zhi, Shih Natalie, Feldman Michael D, Peck Kristen N, DeMichele Angela M, Alwine James C, Robertson Erle S: Distinct Microbial Signatures Associated With Different Breast Cancer Types. Frontiers in microbiology 9: 951, 2018.

Turner, N. C., Finn, R. S., Martin, M., Im, S. A., DeMichele, A., Ettl, J., Dieras, V., Moulder, S., Lipatov, O., Colleoni, M., Cristofanilli, M., Lu, D. R., Mori, A., Giorgetti, C., Iyer, S., Bartlett, C. H., Gelmon, K. A.: Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases. Ann Oncol 29(3): 669-680, 2018.

Sturgeon, K. M., Hackley, R., Fornash, A., Dean, L. T., Laudermilk, M., Brown, J. C., Sarwer, D. B., DeMichele, A. M., Troxel, A. B., Schmitz, K. H.: Strategic recruitment of an ethnically diverse cohort of overweight survivors of breast cancer with lymphedema. Cancer 124(1): 95-104, 2018.

O'Shaughnessy, J., DeMichele, A., Ma, C. X., Richards, P., Yardley, D. A., Wright, G. S., Kalinsky, K., Steis, R., Diab, S., Kennealey, G., Geschwindt, R., Jiang, W., Rugo, H. S.: A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation. Breast Cancer Res Treat 2018.

McAndrew, N., DeMichele, A.: Neoadjuvant Chemotherapy Considerations in Triple-Negative Breast Cancer. J Target Ther Cancer 7(1): 52-69, 2018.

Heymach, J., Krilov, L., Alberg, A., Baxter, N., Chang, S. M., Corcoran, R., Dale, W., DeMichele, A., Magid Diefenbach, C. S., Dreicer, R., Epstein, A. S., Gillison, M. L., Graham, D. L., Jones, J., Ko, A. H., Lopez, A. M., Maki, R. G., Rodriguez-Galindo, C., Schilsky, R. L., Sznol, M., Westin, S. N., Burstein, H.: Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. J Clin Oncol 36(10): 1020-1044, 2018.

Cochran JM, Chung SH, Leproux A, Baker WB, Busch DR, DeMichele AM, Tchou J, Tromberg BJ, Yodh AG: Longitudinal optical monitoring of blood flow in breast tumors during neoadjuvant chemotherapy. Phys Med Biol 62(12): 4637-4653, June 2017.

Homer MV, Charo LM, Natarajan L, Haunschild C, Chung K, Mao JJ, DeMichele AM, Su HI : Genetic variants of age at menopause are not related to timing of ovarian failure in breast cancer survivors Menopause. (eds.). 24(6): 663-668, June 2017.

Maxwell KN, Soucier-Ernst D, Tahirovic E, Troxel AB, Clark C, Feldman M, Colameco C, Kakrecha B, Langer M, Lieberman D, Morrissette JJD, Paul MR, Pan TC, Yee S, Shih N, Carpenter E, Chodosh LA, DeMichele A: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer. Breast Cancer Res Treat. (eds.). May 2017.

back to top
Last updated: 10/17/2018
The Trustees of the University of Pennsylvania